Tranquis Therapeutics presents positive preclinical data on TQS-168 for the treatment of ALS Clinical Impact Nov 3 Written By Frances Benson https://www.tranquis.com/pressrelease/tranquis-therapeutics-presents-positive-preclinical-data-on-tqs-168-for-the-treatment-of-als-at-neuroscience-2021-annual-meeting/ 2021 Frances Benson
Tranquis Therapeutics presents positive preclinical data on TQS-168 for the treatment of ALS Clinical Impact Nov 3 Written By Frances Benson https://www.tranquis.com/pressrelease/tranquis-therapeutics-presents-positive-preclinical-data-on-tqs-168-for-the-treatment-of-als-at-neuroscience-2021-annual-meeting/ 2021 Frances Benson
